Nearly everyone in Ireland over a certain age has heard of the drug Thalidomide. It was given to pregnant women to eliminate morning sickness but led to unwanted changes in the foetus some of whom were born without one or several limbs. Here is more detail from Wikipedia about thalidomide.
There was a certain element of déjà vu when reports in the Irish Medical Times recently announced an inquiry into another drug which pregnant women were prescribed to control their epilepsy. It was reported in the Irish Times in July 2025 that basic justice has not been met for this issue.
The drug, sodium valproate, purchased in Ireland under the trade name Epilim, was more than useful in controlling their epileptic fits but posed a risk of congenital malformation to any children exposed to the drug in the womb. It also brought about serious development disorders in other children equally exposed.
The government appointed barrister Brid O’Flaherty, a medical negligence practitioner, to chair an inquiry into the use of the drug among pregnant women in Ireland. Similar enquiries have been set up in the UK and elsewhere.
The chairwoman will review the way the drug which has been regularly prescribed in Ireland, as well as, perhaps more importantly, the timeline of scientific knowledge about the product’s disastrous effects on foetal development in the womb. Also in her brief is an examination of safety concerns around the treatment and to make recommendations as necessary.
The statistics do not make for pleasant reading. Between 1975 and 2015 350 children experienced congenital malformation when their mothers were prescribed the drug during pregnancy. On an even more dramatic note, in January last GP were warned about the possible side-effects arising from the use of the drug by men during the months leading up to conception.
Studies and research undertaken indicated an increased risk of a range of neurodevelopmental disorders such as delayed learning, ADHD and autism in children, whose fathers were treated with the drug Epilim during the months before conception.
It is to be hoped that the issues around Epilim will be sorted in the not too distant future compared with the long drawn out legal battles surrounding Thalidomide over the last 50 years or so.
Cleary & Co. Solicitors – Litigation Law Firm
Principal Solicitor | Cleary & Co. Solicitors
Kieran Cleary is the principal solicitor at Cleary & Co. Solicitors. He holds a Bachelor of Civil Law (BCL) degree from University College Cork and is a qualified solicitor through the Law Society of Ireland.
With many years of experience, Kieran has developed a strong reputation for his work in personal injury & medical negligence law, representing clients in a wide range of complex cases involving medical negligence. His approach is marked by a deep understanding of procedural law and a strong commitment to securing the best outcomes for his clients.
Contact details are (01) 546 1121 or (052) 612 1999 or our email address is info@clearysolicitors.com
Cleary & Co. have many years of experience specialising in civil law medical negligence cases and if we can help we will.
Kieran Cleary and Roger Cleary, Medical Negligence Solicitors can help with questions you may have regarding negligence, liability, case viability etc. and our numbers are (01) 546 1121 or (052) 612 1999 or our email address is info@clearysolicitors.com
Personal Injuries * In contentious business, a Solicitor may not calculate fees or other charges as a percentage or proportion of any award or settlement.

Need Legal Advice ? No Problem. Contact Us Today !
We help people injured due to negligence attain restitution to their pre-incident position, as much as is possible, for the pain, suffering & financial loss, by seeking damages from the negligent party on their behalf.
Disclaimer
Please be advised that the above-mentioned material is intended as an overview and as a broad out-line of the topic discussed. It should not be considered as complete and comprehensive legal advice, nor act as an appropriate substitute.
Due care has been taken in the publication of this article and we do not accept legal liability as a result of reliance on any material covered in the above article.